This inventor holds 4 USPTO granted patents and 1 EPO patent. Top assignees: Owkin France Sas, Owkin, Inc., Centre Leon Berard. Active years: 2023-2025.
Company Filing History:
4 out of 7 
4 out of 7 
1 out of 39 
Years Active: 2023-2025
Title: Charles Maussion: Innovator in Medical Imaging Technology
Introduction
Charles Maussion is a prominent inventor based in Paris, France. He has made significant contributions to the field of medical imaging technology, particularly in the detection and classification of mesothelioma. With a total of 4 patents to his name, Maussion's work is at the forefront of innovation in healthcare.
Latest Patents
One of his latest patents is titled "Systems and methods for mesothelioma feature detection and enhanced prognosis or response to treatment." This invention describes a method and apparatus that classifies mesothelioma images. The device segments the image into a region of interest and a background region using a convolutional neural network. It further tiles the region of interest into smaller sections and extracts feature vectors for classification. Another notable patent is "Systems and methods for image preprocessing," which employs a similar approach to classify images effectively.
Career Highlights
Throughout his career, Charles Maussion has worked with notable companies such as Owkin, Inc. and Owkin France Sas. His innovative approaches have significantly impacted the medical imaging landscape, enhancing the accuracy of diagnoses and treatment responses.
Collaborations
Maussion has collaborated with esteemed colleagues, including Gilles Wainrib and Pierre Courtiol. These partnerships have fostered a collaborative environment that promotes the advancement of technology in medical imaging.
Conclusion
Charles Maussion's contributions to medical imaging technology exemplify the power of innovation in improving healthcare outcomes. His patents reflect a commitment to enhancing diagnostic capabilities and treatment efficacy.